Cutaneous Metastasis from Gastric Carcinoma, an Uncommon Clinical Presentation

Main Article Content

Fabrizio Vittorio Galimberti
Gregory Perez



Cutaneous metastases are a late event associated with poor prognosis. Here we report a case of gastric carcinoma associated cutaneous metastasis in a patient who reported a history of an unspecified malignancy under remission. This case report serves to highlight cutaneous metastases as a rare late complications of malignancies, including those that may have been previously considered in remission, associated with poor prognosis.


1. Alcaraz I, Cerroni L, Rütten A, Kutzner H, Requena L. Cutaneous metastases from internal malignancies: a clinicopathologic and immunohistochemical review. Am. J. Dermatopathol. 2012;34(4):347–93

2. Sittart JA de S, Senise M. Cutaneous metastasis from internal carcinomas: a review of 45 years. An. Bras. Dermatol. 2013;88(4):541–4

3. Wong CYB, Helm MA, Kalb RE, Helm TN, Zeitouni NC. The presentation, pathology, and current management strategies of cutaneous metastasis. North Am. J. Med. Sci. 2013;5(9):499–504

4. Lookingbill DP, Spangler N, Sexton FM. Skin involvement as the presenting sign of internal carcinoma. A retrospective study of 7316 cancer patients. J. Am. Acad. Dermatol. 1990;22(1):19–26

5. Sitarz R, Skierucha M, Mielko J, Offerhaus GJA, Maciejewski R, Polkowski WP. Gastric cancer: epidemiology, prevention, classification, and treatment. Cancer Manag. Res. 2018;10:239–48

6. Karimi P, Islami F, Anandasabapathy S, Freedman ND, Kamangar F. Gastric cancer: descriptive epidemiology, risk factors, screening, and prevention. Cancer Epidemiol. Biomark. Prev. Publ. Am. Assoc. Cancer Res. Cosponsored Am. Soc. Prev. Oncol. 2014;23(5):700–13

7. Gunturu KS, Woo Y, Beaubier N, Remotti HE, Saif MW. Gastric cancer and trastuzumab: first biologic therapy in gastric cancer. Ther. Adv. Med. Oncol. 2013;5(2):143–51

8. Fujitani K, Yang H-K, Mizusawa J, Kim Y-W, Terashima M, Han S-U, et al. Gastrectomy plus chemotherapy versus chemotherapy alone for advanced gastric cancer with a single non-curable factor (REGATTA): a phase 3, randomised controlled trial. Lancet Oncol. 2016;17(3):309–18

Similar Articles

You may also start an advanced similarity search for this article.